JP2013533226A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013533226A5 JP2013533226A5 JP2013513575A JP2013513575A JP2013533226A5 JP 2013533226 A5 JP2013533226 A5 JP 2013533226A5 JP 2013513575 A JP2013513575 A JP 2013513575A JP 2013513575 A JP2013513575 A JP 2013513575A JP 2013533226 A5 JP2013533226 A5 JP 2013533226A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- group
- seq
- agents
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003795 chemical substances by application Substances 0.000 claims 27
- 238000000034 method Methods 0.000 claims 22
- 125000003710 aryl alkyl group Chemical group 0.000 claims 21
- 125000000623 heterocyclic group Chemical group 0.000 claims 21
- 125000003118 aryl group Chemical group 0.000 claims 19
- 125000002015 acyclic group Chemical group 0.000 claims 18
- 125000001931 aliphatic group Chemical group 0.000 claims 18
- 229940079593 drug Drugs 0.000 claims 17
- 239000003814 drug Substances 0.000 claims 17
- 230000015572 biosynthetic process Effects 0.000 claims 15
- 238000003786 synthesis reaction Methods 0.000 claims 15
- 150000001413 amino acids Chemical group 0.000 claims 14
- 125000004446 heteroarylalkyl group Chemical group 0.000 claims 13
- -1 alkyl radical Chemical class 0.000 claims 10
- 239000000203 mixture Substances 0.000 claims 10
- 230000003796 beauty Effects 0.000 claims 9
- 239000000021 stimulant Substances 0.000 claims 9
- 125000000217 alkyl group Chemical group 0.000 claims 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims 7
- 150000003839 salts Chemical class 0.000 claims 7
- 210000003491 skin Anatomy 0.000 claims 7
- 125000004432 carbon atom Chemical group C* 0.000 claims 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 4
- 230000003712 anti-aging effect Effects 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 4
- 230000035755 proliferation Effects 0.000 claims 4
- 239000000463 material Substances 0.000 claims 3
- 239000000693 micelle Substances 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 108030001720 Bontoxilysin Proteins 0.000 claims 2
- 102000016942 Elastin Human genes 0.000 claims 2
- 108010014258 Elastin Proteins 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims 2
- URLZCHNOLZSCCA-VABKMULXSA-N Leu-enkephalin Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(O)=O)NC(=O)CNC(=O)CNC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 URLZCHNOLZSCCA-VABKMULXSA-N 0.000 claims 2
- 239000000853 adhesive Substances 0.000 claims 2
- 230000001070 adhesive effect Effects 0.000 claims 2
- 210000001789 adipocyte Anatomy 0.000 claims 2
- 239000002671 adjuvant Substances 0.000 claims 2
- 239000003429 antifungal agent Substances 0.000 claims 2
- 239000007844 bleaching agent Substances 0.000 claims 2
- 229940053031 botulinum toxin Drugs 0.000 claims 2
- 230000015556 catabolic process Effects 0.000 claims 2
- 239000006071 cream Substances 0.000 claims 2
- 238000006731 degradation reaction Methods 0.000 claims 2
- 230000004069 differentiation Effects 0.000 claims 2
- 229920002549 elastin Polymers 0.000 claims 2
- 239000000284 extract Substances 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 230000003779 hair growth Effects 0.000 claims 2
- 239000003112 inhibitor Substances 0.000 claims 2
- 210000002510 keratinocyte Anatomy 0.000 claims 2
- 150000002632 lipids Chemical class 0.000 claims 2
- 239000002502 liposome Substances 0.000 claims 2
- 239000006210 lotion Substances 0.000 claims 2
- 210000004080 milk Anatomy 0.000 claims 2
- 235000013336 milk Nutrition 0.000 claims 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims 2
- 239000000049 pigment Substances 0.000 claims 2
- 239000000843 powder Substances 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000004094 surface-active agent Substances 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- 102000008490 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Human genes 0.000 claims 1
- 108010020504 2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine Proteins 0.000 claims 1
- LKDMKWNDBAVNQZ-UHFFFAOYSA-N 4-[[1-[[1-[2-[[1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-oxobutanoic acid Chemical compound OC(=O)CCC(=O)NC(C)C(=O)NC(C)C(=O)N1CCCC1C(=O)NC(C(=O)NC=1C=CC(=CC=1)[N+]([O-])=O)CC1=CC=CC=C1 LKDMKWNDBAVNQZ-UHFFFAOYSA-N 0.000 claims 1
- 229940113178 5 Alpha reductase inhibitor Drugs 0.000 claims 1
- 239000002677 5-alpha reductase inhibitor Substances 0.000 claims 1
- 235000007173 Abies balsamea Nutrition 0.000 claims 1
- 102000012440 Acetylcholinesterase Human genes 0.000 claims 1
- 108010022752 Acetylcholinesterase Proteins 0.000 claims 1
- 102000010637 Aquaporins Human genes 0.000 claims 1
- 108010063290 Aquaporins Proteins 0.000 claims 1
- 241000195940 Bryophyta Species 0.000 claims 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims 1
- 102000004173 Cathepsin G Human genes 0.000 claims 1
- 108090000617 Cathepsin G Proteins 0.000 claims 1
- 208000035484 Cellulite Diseases 0.000 claims 1
- 108010009685 Cholinergic Receptors Proteins 0.000 claims 1
- 102000008186 Collagen Human genes 0.000 claims 1
- 108010035532 Collagen Proteins 0.000 claims 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 claims 1
- 229920000858 Cyclodextrin Polymers 0.000 claims 1
- 102000004127 Cytokines Human genes 0.000 claims 1
- 108090000695 Cytokines Proteins 0.000 claims 1
- 230000033616 DNA repair Effects 0.000 claims 1
- 102000004237 Decorin Human genes 0.000 claims 1
- 108090000738 Decorin Proteins 0.000 claims 1
- 102000000541 Defensins Human genes 0.000 claims 1
- 108010002069 Defensins Proteins 0.000 claims 1
- 102000016359 Fibronectins Human genes 0.000 claims 1
- 108010067306 Fibronectins Proteins 0.000 claims 1
- 229940123457 Free radical scavenger Drugs 0.000 claims 1
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 1
- 102000004157 Hydrolases Human genes 0.000 claims 1
- 108090000604 Hydrolases Proteins 0.000 claims 1
- 244000018716 Impatiens biflora Species 0.000 claims 1
- 108010006519 Molecular Chaperones Proteins 0.000 claims 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims 1
- 102000008299 Nitric Oxide Synthase Human genes 0.000 claims 1
- 108010021487 Nitric Oxide Synthase Proteins 0.000 claims 1
- 206010049752 Peau d'orange Diseases 0.000 claims 1
- 229940078467 Prolyl hydroxylase inhibitor Drugs 0.000 claims 1
- 102000012479 Serine Proteases Human genes 0.000 claims 1
- 108010022999 Serine Proteases Proteins 0.000 claims 1
- 102000011990 Sirtuin Human genes 0.000 claims 1
- 108050002485 Sirtuin Proteins 0.000 claims 1
- 208000031439 Striae Distensae Diseases 0.000 claims 1
- 102000034337 acetylcholine receptors Human genes 0.000 claims 1
- 229940022698 acetylcholinesterase Drugs 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 239000000443 aerosol Substances 0.000 claims 1
- 230000002776 aggregation Effects 0.000 claims 1
- 238000004220 aggregation Methods 0.000 claims 1
- 238000003915 air pollution Methods 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 229940061720 alpha hydroxy acid Drugs 0.000 claims 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims 1
- 239000002269 analeptic agent Substances 0.000 claims 1
- 229940035674 anesthetics Drugs 0.000 claims 1
- 230000033115 angiogenesis Effects 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940121363 anti-inflammatory agent Drugs 0.000 claims 1
- 239000002260 anti-inflammatory agent Substances 0.000 claims 1
- 230000001166 anti-perspirative effect Effects 0.000 claims 1
- 230000002682 anti-psoriatic effect Effects 0.000 claims 1
- 230000002421 anti-septic effect Effects 0.000 claims 1
- 230000001153 anti-wrinkle effect Effects 0.000 claims 1
- 229940121375 antifungal agent Drugs 0.000 claims 1
- 239000000739 antihistaminic agent Substances 0.000 claims 1
- 229940125715 antihistaminic agent Drugs 0.000 claims 1
- 239000003963 antioxidant agent Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 239000003096 antiparasitic agent Substances 0.000 claims 1
- 229940125687 antiparasitic agent Drugs 0.000 claims 1
- 239000003213 antiperspirant Substances 0.000 claims 1
- 239000003908 antipruritic agent Substances 0.000 claims 1
- 229940064004 antiseptic throat preparations Drugs 0.000 claims 1
- 239000003443 antiviral agent Substances 0.000 claims 1
- 239000002249 anxiolytic agent Substances 0.000 claims 1
- 150000005840 aryl radicals Chemical class 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 239000000022 bacteriostatic agent Substances 0.000 claims 1
- 150000001277 beta hydroxy acids Chemical class 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000002775 capsule Substances 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 230000019522 cellular metabolic process Effects 0.000 claims 1
- 229940106189 ceramide Drugs 0.000 claims 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims 1
- 239000002738 chelating agent Substances 0.000 claims 1
- 229920001436 collagen Polymers 0.000 claims 1
- 230000011382 collagen catabolic process Effects 0.000 claims 1
- 239000003086 colorant Substances 0.000 claims 1
- 238000004040 coloring Methods 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 claims 1
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 210000004207 dermis Anatomy 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000003602 elastase inhibitor Substances 0.000 claims 1
- 238000004520 electroporation Methods 0.000 claims 1
- 239000003974 emollient agent Substances 0.000 claims 1
- 239000003995 emulsifying agent Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 210000000981 epithelium Anatomy 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 210000002950 fibroblast Anatomy 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000003205 fragrance Substances 0.000 claims 1
- 239000000417 fungicide Substances 0.000 claims 1
- 239000003193 general anesthetic agent Substances 0.000 claims 1
- 239000003102 growth factor Substances 0.000 claims 1
- 239000003966 growth inhibitor Substances 0.000 claims 1
- 230000035876 healing Effects 0.000 claims 1
- 239000013003 healing agent Substances 0.000 claims 1
- 229920002674 hyaluronan Polymers 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 239000000017 hydrogel Substances 0.000 claims 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 238000007918 intramuscular administration Methods 0.000 claims 1
- 238000007912 intraperitoneal administration Methods 0.000 claims 1
- 239000007928 intraperitoneal injection Substances 0.000 claims 1
- 238000001990 intravenous administration Methods 0.000 claims 1
- 239000000865 liniment Substances 0.000 claims 1
- 229940040145 liniment Drugs 0.000 claims 1
- 230000004130 lipolysis Effects 0.000 claims 1
- 230000002366 lipolytic effect Effects 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000003771 matrix metalloproteinase inhibitor Substances 0.000 claims 1
- 229940121386 matrix metalloproteinase inhibitor Drugs 0.000 claims 1
- 230000008099 melanin synthesis Effects 0.000 claims 1
- 210000002752 melanocyte Anatomy 0.000 claims 1
- 239000004530 micro-emulsion Substances 0.000 claims 1
- 239000003094 microcapsule Substances 0.000 claims 1
- 230000004089 microcirculation Effects 0.000 claims 1
- 238000000520 microinjection Methods 0.000 claims 1
- 239000011859 microparticle Substances 0.000 claims 1
- 239000004005 microsphere Substances 0.000 claims 1
- 230000003020 moisturizing effect Effects 0.000 claims 1
- 235000011929 mousse Nutrition 0.000 claims 1
- 230000004118 muscle contraction Effects 0.000 claims 1
- 239000002088 nanocapsule Substances 0.000 claims 1
- 239000007908 nanoemulsion Substances 0.000 claims 1
- 239000002105 nanoparticle Substances 0.000 claims 1
- 239000002077 nanosphere Substances 0.000 claims 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims 1
- 239000002353 niosome Substances 0.000 claims 1
- 239000004745 nonwoven fabric Substances 0.000 claims 1
- 239000003921 oil Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 claims 1
- 239000002674 ointment Substances 0.000 claims 1
- 239000003960 organic solvent Substances 0.000 claims 1
- 230000003204 osmotic effect Effects 0.000 claims 1
- 230000003711 photoprotective effect Effects 0.000 claims 1
- 239000000419 plant extract Substances 0.000 claims 1
- 230000008569 process Effects 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 239000003380 propellant Substances 0.000 claims 1
- 239000003223 protective agent Substances 0.000 claims 1
- 230000001012 protector Effects 0.000 claims 1
- 239000002516 radical scavenger Substances 0.000 claims 1
- 150000003254 radicals Chemical class 0.000 claims 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims 1
- 210000002374 sebum Anatomy 0.000 claims 1
- 229940125723 sedative agent Drugs 0.000 claims 1
- 239000000932 sedative agent Substances 0.000 claims 1
- 230000037307 sensitive skin Effects 0.000 claims 1
- 239000002453 shampoo Substances 0.000 claims 1
- 239000000344 soap Substances 0.000 claims 1
- 239000002047 solid lipid nanoparticle Substances 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 239000007921 spray Substances 0.000 claims 1
- 239000003381 stabilizer Substances 0.000 claims 1
- 210000000434 stratum corneum Anatomy 0.000 claims 1
- 239000007929 subcutaneous injection Substances 0.000 claims 1
- 238000010254 subcutaneous injection Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000000475 sunscreen effect Effects 0.000 claims 1
- 239000000516 sunscreening agent Substances 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 239000002562 thickening agent Substances 0.000 claims 1
- 235000015961 tonic Nutrition 0.000 claims 1
- 230000001256 tonic effect Effects 0.000 claims 1
- 229960000716 tonics Drugs 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
- 230000008728 vascular permeability Effects 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
- 239000000341 volatile oil Substances 0.000 claims 1
- 239000000080 wetting agent Substances 0.000 claims 1
- 230000037303 wrinkles Effects 0.000 claims 1
- FVNHWRVYVUYECZ-UHFFFAOYSA-N CCC(C)(C(C)=O)NCCCOCCOCCOCCCNC(CCC1=[O]CC1(C)C)=O Chemical compound CCC(C)(C(C)=O)NCCCOCCOCCOCCCNC(CCC1=[O]CC1(C)C)=O FVNHWRVYVUYECZ-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/797,222 US20110305735A1 (en) | 2010-06-09 | 2010-06-09 | Skin antiaging treatment |
| US12/797,222 | 2010-06-09 | ||
| PCT/EP2011/002799 WO2011154126A2 (en) | 2010-06-09 | 2011-06-08 | Skin antiaging treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017206549A Division JP2018058842A (ja) | 2010-06-09 | 2017-10-25 | 皮膚の抗老化治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013533226A JP2013533226A (ja) | 2013-08-22 |
| JP2013533226A5 true JP2013533226A5 (enExample) | 2014-07-24 |
| JP6306885B2 JP6306885B2 (ja) | 2018-04-04 |
Family
ID=44627143
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013513575A Active JP6306885B2 (ja) | 2010-06-09 | 2011-06-08 | 皮膚の抗老化治療 |
| JP2017206549A Pending JP2018058842A (ja) | 2010-06-09 | 2017-10-25 | 皮膚の抗老化治療 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017206549A Pending JP2018058842A (ja) | 2010-06-09 | 2017-10-25 | 皮膚の抗老化治療 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20110305735A1 (enExample) |
| EP (1) | EP2579952B1 (enExample) |
| JP (2) | JP6306885B2 (enExample) |
| KR (4) | KR20210090731A (enExample) |
| CN (1) | CN103096980B (enExample) |
| AU (1) | AU2011264125B2 (enExample) |
| BR (1) | BR112012031117B1 (enExample) |
| CA (1) | CA2801961C (enExample) |
| CO (1) | CO6640331A2 (enExample) |
| ES (1) | ES2654342T3 (enExample) |
| MX (1) | MX342853B (enExample) |
| WO (1) | WO2011154126A2 (enExample) |
| ZA (1) | ZA201209484B (enExample) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9486408B2 (en) * | 2005-12-01 | 2016-11-08 | University Of Massachusetts Lowell | Botulinum nanoemulsions |
| EP2482838A4 (en) * | 2009-09-30 | 2013-04-10 | Toxcure Inc | USE OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF SUBSTANCE DEPENDENCE |
| US9233062B2 (en) | 2011-05-10 | 2016-01-12 | Mary Kay Inc. | Cosmetic compositions |
| JP5889220B2 (ja) * | 2012-03-30 | 2016-03-22 | 富士フイルム株式会社 | 水性分散組成物 |
| EP2649984A1 (en) * | 2012-04-13 | 2013-10-16 | Lipotec, S.A. | Compounds which inhibit neuronal exocytosis |
| US8758783B1 (en) | 2012-12-20 | 2014-06-24 | L'oreal | Water-in-oil emulsion comprising pigments in the water phase |
| RU2524663C1 (ru) * | 2013-04-26 | 2014-07-27 | Общество с ограниченной ответственностью "ДЖИ-Групп" | Комплексное косметическое средство |
| CN103505377B (zh) * | 2013-09-11 | 2015-06-03 | 深圳市维琪医药研发有限公司 | 一种具皮肤活性的多肽组合物 |
| CA2928526A1 (en) | 2013-11-01 | 2015-05-07 | Spherium Biomed S.L. | Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents |
| CN103641888B (zh) * | 2013-12-03 | 2015-08-12 | 广州健坤生物科技有限公司 | 一种多功能新型小肽、包含该肽的组合物及其应用 |
| CN103637925B (zh) * | 2013-12-03 | 2015-09-30 | 广州健坤生物科技有限公司 | γ-氨基丁酸(GABA)和一种小肽在化妆品中的联合应用 |
| CN104000744A (zh) * | 2014-06-12 | 2014-08-27 | 金玲 | 一种改善肌肤新陈代谢并能延缓衰老的美容用液及其生产方法 |
| CN107205889B (zh) * | 2014-09-02 | 2021-05-11 | 美国白银有限责任公司 | 肉毒毒素和胶体银颗粒 |
| CN107427474A (zh) | 2015-04-13 | 2017-12-01 | 株式会社Lg生活健康 | 含有调节神经递质释放的成分的可溶性微针 |
| WO2016167545A1 (ko) * | 2015-04-13 | 2016-10-20 | 주식회사 엘지생활건강 | 신경전달물질의 배출을 조절하는 성분이 포함된 용해성 마이크로니들 |
| KR102203633B1 (ko) * | 2015-04-14 | 2021-01-15 | 주식회사 엘지생활건강 | 칼슘채널 차단제 전달용 용해성 미세바늘 |
| KR101843065B1 (ko) * | 2016-01-06 | 2018-03-28 | 바이오스펙트럼 주식회사 | 카노신, 대두 펩타이드 및 천심련 추출물을 포함하는 항노화용 조성물 |
| US10493020B2 (en) | 2016-04-14 | 2019-12-03 | The Procter & Gamble Company | Method of improving the appearance of periorbital dyschromia |
| US11478409B2 (en) * | 2016-05-24 | 2022-10-25 | Natura Cosmeticos S.A. | Anti-wrinkle cosmetic composition, composition system and method for cosmetic skin treatment |
| KR101895906B1 (ko) * | 2016-07-07 | 2018-10-04 | 주식회사 한국화장품제조 | 펩타이드 리포좀을 포함하는 스틱형 화장료 조성물 |
| US20180133131A1 (en) * | 2016-11-14 | 2018-05-17 | Ariix | Skin rejuvenating compositions |
| US11311496B2 (en) | 2016-11-21 | 2022-04-26 | Eirion Therapeutics, Inc. | Transdermal delivery of large agents |
| JP7191386B2 (ja) * | 2017-02-24 | 2022-12-19 | リポトゥルー，エセ．エレ． | 化粧料に使用するためのペプチドおよび組成物 |
| US10258556B2 (en) * | 2017-06-19 | 2019-04-16 | Yu-Chun Liu | Anti-aging peptide, its composition and method of using the same |
| KR102311724B1 (ko) * | 2017-09-15 | 2021-10-13 | (주)아모레퍼시픽 | 슈도알터로모나스 펩티도라이티카의 배양물 또는 이의 추출물을 포함하는 피부 미백용 조성물 |
| CN107693391A (zh) * | 2017-11-21 | 2018-02-16 | 上海合轩品牌管理有限公司 | 一种抗皱眼霜及其制备方法 |
| KR102041561B1 (ko) * | 2018-02-23 | 2019-11-06 | 주식회사 메디쿼터스 | 미세먼지 차단용 피부화장료 조성물 및 겔 조성물 |
| US11191819B2 (en) * | 2018-08-28 | 2021-12-07 | Ira Sanders | Skin therapeutics |
| CN109293737B (zh) * | 2018-09-27 | 2020-10-27 | 华南理工大学 | 一种抗皮肤衰老的四肽及其用途 |
| KR102139472B1 (ko) * | 2018-10-31 | 2020-07-30 | 에이앤펩주식회사 | 기능성 펩타이드와 발효물을 포함하는 피부노화 개선용 조성물 |
| EP4393504A2 (en) * | 2018-12-26 | 2024-07-03 | Skinmed Co., Ltd. | Acetylcholine receptor inhibitory peptides and uses thereof |
| GB202004804D0 (en) * | 2020-04-01 | 2020-05-13 | Neuro Bio Ltd | Skin |
| CN111904881B (zh) * | 2020-08-11 | 2023-05-23 | 上海科颜生物科技有限公司 | 一种抗衰紧致组合物及其制备方法和应用 |
| CN113307851B (zh) * | 2021-06-11 | 2022-04-29 | 珠海医美企业管理有限公司 | 一种改善皮肤生理特性的活性肽与间充质干细胞外泌体在药品或化妆品中的应用 |
| CN113577364A (zh) * | 2021-08-13 | 2021-11-02 | 常州谙美生物科技有限公司 | 一种用于晒后修复的医用敷料 |
| CN115400043B (zh) * | 2022-08-04 | 2023-10-31 | 广州环亚化妆品科技股份有限公司 | 一种抗皱组合物及其制备方法和在化妆品中的应用 |
| CN116003518B (zh) * | 2023-01-10 | 2023-09-29 | 深圳市维琪科技股份有限公司 | 经设计的肽及其组合物和用途 |
| CN116747148B (zh) * | 2023-07-24 | 2024-10-01 | 山东福瑞达生物股份有限公司 | 一种适用于敏感肌的抗衰化妆品组合物 |
| KR102834921B1 (ko) * | 2023-08-14 | 2025-07-18 | 허가영 | 조직수복 및 피부탄력 개선용 조성물 |
| CN117297997B (zh) * | 2023-11-28 | 2024-03-19 | 杭州湃肽生化科技有限公司 | 一种高效紧肤多肽组合物及其产品应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE228834T1 (de) | 1994-09-30 | 2002-12-15 | Oreal | Verwendung von einem agonisten eines mit einem chloridkanal assozierten rezeptors zur behandlung von hautfalten |
| AU2334897A (en) * | 1996-03-18 | 1997-10-10 | Regents Of The University Of California, The | Peptide inhibitors of neurotransmitter secretion by neuronal cells |
| FR2746641B1 (fr) | 1996-03-27 | 1998-06-05 | Oreal | Utilisation d'un extrait d'au moins une iridacee dans le traitement des rides |
| ES2160485B1 (es) | 1999-04-23 | 2002-05-16 | Lipotec Sa | Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen. |
| FR2798590B1 (fr) | 1999-09-21 | 2001-11-30 | Oreal | Utilisation de l'alverine pour diminuer les rides |
| US7780967B2 (en) * | 2000-02-08 | 2010-08-24 | Allergan, Inc. | Reduced toxicity Clostridial toxin pharmaceutical compositions |
| FR2809005B1 (fr) | 2000-05-18 | 2002-12-27 | Oreal | Utilisation du manganese dans le traitement des rides |
| FR2846885B1 (fr) | 2002-11-13 | 2004-12-24 | Oreal | Utilisation d'une association de composants a effet synergique inhibiteur de canaux calciques pour prevenir ou traiter les ridules |
| ES2259928B1 (es) | 2005-04-08 | 2007-11-01 | Lipotec, S.A. | Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales. |
| ES2322882B1 (es) * | 2006-10-25 | 2010-04-22 | Lipotec Sa | Peptidos inhibidores de la exocitosis neuronal. |
-
2010
- 2010-06-09 US US12/797,222 patent/US20110305735A1/en not_active Abandoned
-
2011
- 2011-06-08 CN CN201180035848.2A patent/CN103096980B/zh active Active
- 2011-06-08 KR KR1020217021742A patent/KR20210090731A/ko not_active Ceased
- 2011-06-08 EP EP11725874.9A patent/EP2579952B1/en active Active
- 2011-06-08 WO PCT/EP2011/002799 patent/WO2011154126A2/en not_active Ceased
- 2011-06-08 KR KR1020187020082A patent/KR20180083958A/ko not_active Ceased
- 2011-06-08 BR BR112012031117-4A patent/BR112012031117B1/pt active IP Right Grant
- 2011-06-08 MX MX2012014389A patent/MX342853B/es active IP Right Grant
- 2011-06-08 KR KR1020197035199A patent/KR20190135555A/ko not_active Ceased
- 2011-06-08 CA CA2801961A patent/CA2801961C/en active Active
- 2011-06-08 KR KR1020137000438A patent/KR20130135819A/ko not_active Ceased
- 2011-06-08 JP JP2013513575A patent/JP6306885B2/ja active Active
- 2011-06-08 ES ES11725874.9T patent/ES2654342T3/es active Active
- 2011-06-08 AU AU2011264125A patent/AU2011264125B2/en active Active
-
2012
- 2012-12-13 ZA ZA2012/09484A patent/ZA201209484B/en unknown
- 2012-12-28 CO CO12235622A patent/CO6640331A2/es not_active Application Discontinuation
-
2017
- 2017-10-25 JP JP2017206549A patent/JP2018058842A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013533226A5 (enExample) | ||
| CN103096980B (zh) | 皮肤抗衰老治疗 | |
| EP2651428B1 (en) | Pgc-1alpha-modulating peptides | |
| AU2009218680B2 (en) | Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors | |
| JP2019502677A5 (enExample) | ||
| JP5570978B2 (ja) | 新規化合物、化粧品用途および薬用化粧品用途におけるその使用、および該化合物を含む組成物 | |
| RU2012118581A (ru) | Пептиды, используемые в лечении и/или наблюдении за кожей, слизистыми оболочками и/или волосами, и их применение в косметических или фармацевтических композициях | |
| JP2016519105A5 (enExample) | ||
| JP2015514722A5 (enExample) | ||
| BR112020000123A2 (pt) | composto, uso de um composto, composição cosmética, e, método para cuidado e/ou tratamento cosmético não terapêutico da pele, cabelos, unhas e/ou membranas mucosas | |
| JP2015514721A5 (enExample) | ||
| JP5781224B2 (ja) | 保湿能に優れたペプチド誘導体およびその用途 | |
| ES2612237T3 (es) | Exopolisacárido para el tratamiento y/o cuidado de la piel, membranas de mucosas y/o uñas | |
| JP2015514124A5 (enExample) | ||
| US20130078295A1 (en) | Skin antiaging treatment | |
| JP2015514125A5 (enExample) | ||
| BR112012017716B1 (pt) | Composto, e, composição | |
| AU2020364159B2 (en) | Methods for cosmetic skin remodeling |